Real-world clinical outcomes and economic burden of early discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Patel, Jeetvan
Nguyen, Jennifer
Bollu, Vamsi
Kang, Barinder
Sawhney, Amrita
Byrne, Clare
Tang, Jackson
Gorritz, Magdaliz
Chen, Chi-Chang
Shore, Neal D.
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Asclepius Analyt, New York, NY USA
[3] IQVIA Inc, King Of Prussia, PA USA
[4] Carolina Urol Res Ctr, Myrtle Beach, SC USA
[5] GenesisCare US, Myrtle Beach, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17043
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study
    Barata, Pedro C.
    Leith, Andrea
    Ribbands, Amanda
    Montgomery, Rachel
    Last, Matthew
    Arondekar, Bhakti
    Ivanova, Jasmina
    Niyazov, Alexander
    ONCOLOGIST, 2023, 28 (09): : E737 - E747
  • [22] Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Mitchell, Aaron P.
    Meza, Akriti Mishra
    Panageas, Katherine S.
    Lipitz-Snyderman, Allison
    Farooki, Azeez
    Morris, Michael J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 126 - 132
  • [23] Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Aaron P. Mitchell
    Akriti Mishra Meza
    Katherine S. Panageas
    Allison Lipitz-Snyderman
    Azeez Farooki
    Michael J. Morris
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 126 - 132
  • [24] Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Shore, N.
    Ionescu-Ittu, R.
    Yang, L.
    Laliberte, F.
    Payne, S.
    Gayle, A.
    Amin, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S526 - S527
  • [25] Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study
    Liontos, M.
    Bournakis, E.
    Bournakis, A.
    Kostouros, E.
    Zolota, V.
    Papatheodoridi, A. P.
    Karalis, K.
    Kyriazoglou, A.
    Zakopoulou, R.
    Vasili, E.
    Tzovaras, A.
    Dimitriadis, I.
    Emmanouil, G.
    Mauri, D.
    Christodoulou, C.
    Tsiatas, M.
    Zagouri, F.
    Bamias, A.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [26] A real-world registry of patients with metastatic castration-resistant prostate cancer (mCRPC): REMPRO study.
    Gonzalez, Francisco
    Kodagali, Rohit
    Tung, Teresa
    Masoud, Mohamed
    Rajadhyaksha, Viraj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [27] Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide
    Lowentritt, Benjamin H.
    Du, Shawn
    Rossi, Carmine
    Muser, Erik
    Khilfeh, Ibrahim
    Kinkead, Frederic
    Korsiak, Jill
    Lefebvre, Patrick
    Pilon, Dominic
    Agarwal, Neeraj
    FUTURE ONCOLOGY, 2024, 20 (27) : 2005 - 2013
  • [28] Clinical characteristics and outcomes for patients with non‑metastatic castration-resistant prostate cancer
    Peter Arnold
    Maria Cristina Penaloza-Ramos
    Lola Adedokun
    Sarah Rees
    Mohamed Lockhat
    Lisa Spary
    Alan Watkins
    Vincent Gnanapragasam
    Simon J. Crabb
    Scientific Reports, 11
  • [29] Real-world analysis of prostate-specific antigen (PSA) outcomes among patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA)
    Freedland, Stephen J.
    Schultz, Neil M.
    Coutinho, Anna D.
    Fuldeore, Rupali
    Hedlund, Nancy
    Feng, Qi
    Ramaswamy, Krishnan
    Hong, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [30] Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer
    Bracarda, Sergio
    Gernone, Angela
    Gasparro, Donatello
    Marchetti, Paolo
    Ronzoni, Monica
    Bortolus, Roberto
    Fratino, Lucia
    Basso, Umberto
    Mazzanti, Roberto
    Messina, Caterina
    Tucci, Marcello
    Boccardo, Francesco
    Carteni, Giacomo
    Pinto, Carmine
    Fornarini, Giuseppe
    Mattioli, Rodolfo
    Procopio, Giuseppe
    Chiuri, Vincenzo
    Scotto, Tiziana
    Dondi, Davide
    Di Lorenzo, Giuseppe
    FUTURE ONCOLOGY, 2014, 10 (06) : 975 - 983
12345